Several diagnostic approaches are available for IFDs
Conventional testing, which includes:
- Culture
- Direct microscopy
- Histopathology
Non-conventional testing, which includes:
- 1,3-β-D-glucan (BDG) biomarker detection
- Mannan detection
- Cryptococcal antigen testing
- Galactomannan biomarker detection
- Polymerase chain reaction (PCR), including pan-fungal and strain-specific PCR screening assays
Navigate your way through the diagnostic pathway of a patient with clinical signs of infection
References
- Bassetti M et al. Clin Infect Dis. 2021;72:S121–S127.
- De Pauw B et al. Clin Infect Dis. 2008;46:1813–1821.
- Verweij PE et al. Intensive Care Med. 2020;46:1524–1535.
- Koehler P et al. Lancet Infect Dis. 2021;21:e149–e162.
- Cuenca-Estrella M et al. J Antimicrob Chemother. 2011;66:i15–24.
- Terrero-Salcedo D and Powers-Fletcher MV. J Clin Microbiol. 2020;58:e01487-19.
- Donnelly JP et al. Clin Infect Dis. 2020;71:1367–1376.
- Arvanitis M et al. Clin Microbiol Rev. 2014;27:490–526.
- Jenks JD et al. Clin Infect Dis. 2021;73:e1737–44.
- Mikulska M et al. Crit Care. 2010;14:R222.
- Kidd SE et al. Front Microbiol. 2019;10:2903.
- Faculty of Public Health, Health Knowledge. Available at: https://www.healthknowledge.org.uk/public-health-textbook/disease-causation-diagnostic/2c-diagnosis-screening/statistical-aspects-screening. Accessed July 2023.